SOP Guide for Pharma

Elixir Department: SOP for Avoiding Cross-Contamination During Manufacturing – V 2.0

Elixir Department: SOP for Avoiding Cross-Contamination During Manufacturing – V 2.0

Standard Operating Procedure for Avoiding Cross-Contamination During Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/087/2025
Supersedes SOP/ELX/087/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define procedures and preventive measures to eliminate cross-contamination risks during the manufacturing of elixir products and to ensure compliance with GMP guidelines.

2. Scope

This SOP is applicable to all manufacturing activities within the Elixir Department where there is a risk of contamination due to shared equipment, personnel movement, air handling, and material transfers.

3. Responsibilities

  • Production Operator:
    • Follow defined gowning, cleaning, and equipment segregation procedures.
    • Report any potential contamination events immediately.
  • Production Supervisor:
    • Ensure proper scheduling and line clearance between batches.
    • Verify cleaning effectiveness and approve use of shared areas.
  • QA Officer:
    • Conduct environmental monitoring and audit adherence to contamination control practices.

4. Accountability

The Head of Production is accountable for implementation and periodic review of contamination control strategies and for ensuring corrective actions are implemented if risks are identified.

5. Procedure

5.1 Environmental and Facility Controls

  1. Manufacturing areas must be segregated by physical barriers, pressure differentials, or dedicated rooms where feasible.
  2. Maintain proper air filtration (HEPA filters) and HVAC zoning as per cleanroom classification.
  3. Perform cleaning of floors, walls, and surfaces after each batch or product changeover using validated disinfectants.

5.2 Personnel and Gowning

  1. Use dedicated cleanroom garments and accessories for each room.
  2. Follow gowning SOPs strictly and avoid personnel movement between manufacturing areas without gown change.
  3. Limit number of personnel in process areas as per defined occupancy limits.

5.3 Equipment Cleaning and Segregation

  1. Use dedicated or properly cleaned and sanitized equipment for each product.
  2. Perform line clearance and cleaning verification before initiating new batch processing.
  3. Use separate transfer lines and fittings where product nature demands (e.g., alcohol-based vs aqueous-based elixirs).

5.4 Material Handling

  1. Label all materials clearly with product name, batch number, and status (e.g., Approved, Quarantined).
  2. Transport materials in closed containers and along defined material movement routes.
  3. Do not store different product intermediates in the same tank or holding area.

5.5 Scheduling and Campaigning

  1. Where feasible, schedule manufacturing in campaigns of similar products to reduce changeovers.
  2. Avoid simultaneous processing of incompatible or high-risk products within the same room.

5.6 Deviation and Incident Handling

  1. Any suspected cross-contamination must be reported immediately to QA.
  2. Initiate deviation report and investigate with potential root cause analysis.
  3. Take corrective and preventive actions (CAPA) before restarting operations.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • HVAC: Heating, Ventilation, and Air Conditioning

7. Documents

  1. Contamination Risk Assessment Log (Annexure-1)
  2. Cleaning Verification Record (Annexure-2)
  3. Deviation Report Form

8. References

  • 21 CFR Part 211.113 – Control of Microbiological Contamination
  • WHO TRS 986 – GMP for Pharmaceuticals
  • ICH Q9 – Quality Risk Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Contamination Risk Assessment Log

Date Batch No. Risk Identified Preventive Action Operator QA Verified
11/04/2025 ELX-1026 Residual alcohol vapors Delayed next batch by 2 hrs Rajesh Kumar Sunita Reddy

Annexure-2: Cleaning Verification Record

Equipment ID Previous Product Cleaning Date Swab Test Result Verified By Status
MX-04 Multivitamin Elixir 10/04/2025 Pass QA Analyst Ready for Use

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New SOP QA Head
11/04/2025 2.0 Added preventive measures and monitoring logs Audit Observation QA Head
Exit mobile version